Thalidomide April 12, 2017 Thalidomide Trade Name Orphan Indication Primary brain malignancies USA Market Approval USA USA Designation Date 1998-02-27 00:00:00 Sponsor Celgene Corporation;7 Powder Horn Dr.;Warren
